LifeMD (LFMD) Financials

$3.00

$-0.10 (-3.07%)

As on 09-Sep-2026 12:36EDT

Market cap

$148 Mln

Revenue (TTM)

$204 Mln

P/E Ratio

--

P/B Ratio

18.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	204.48	194.06	212.45	152.55	119.03	92.88
Cost of Revenue	28.81	39.29	24.07	18.90	18.67	18.00
Gross Profit	175.67	154.76	188.39	133.65	100.37	74.88
Operating Expenses	194.80	162.43	204.53	148.14	143.81	129.18
Operating Profit (EBIT)	-19.13	-7.67	-16.14	-14.49	-43.45	-54.30
Other Income	--	--	--	--	--	-4.00
Profit before Tax	-20.42	-10.19	-18.33	-17.41	-44.66	-61.32
Provision for Tax	0.96	0.05	0.40	0.43	0.36	0.01
Profit after Tax (Net Income)	-21.26	-7.11	-18.88	-20.60	-45.54	-60.90
Minority Interest	-0.23	-1.27	-0.15	-2.61	0.51	0.43
Consolidated Profit	--	--	--	--	-48.64	-61.77

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	7.97	23.16	-5.49	3.51	-6.83	26.85
Minority Interest	-0.23	--	--	--	-0.48	-1.03
Non-Current Liabilities	5.32	5.68	16.25	18.13	1.60	1.28
Current Liabilities	46.61	41.57	60.26	34.78	31.37	22.83
Total Liabilities	106.50	70.41	72.46	58.48	25.67	49.92

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	17.81	18.58	23.73	15.88	14.35	5.00
Current Assets	42.08	51.83	48.73	42.60	11.31	44.92
Total Assets	106.50	70.41	72.46	58.48	25.67	49.92
Total Debt*	6.02	6.32	25.10	18.93	4.13	1.85
Net Current Assets	-4.52	10.26	-11.52	7.82	-20.06	22.10

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	8.28	17.51	8.82	-22.94	-33.09
Cash Flow from Investing Activities	--	6.91	-11.54	-8.73	-13.91	-3.40
Cash from Financing Activities	--	-13.41	-4.12	29.10	-0.53	68.64
Net Cash Inflow / Outflow	--	--	--	--	-37.37	32.15

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.45	-0.15	-0.45	-0.56	-1.45	-2.28
Cash EPS ($)	--	0.00	-0.22	-0.40	-1.33	-2.25
Adjusted Book Value ($)	--	0.50	--	0.10	--	1.01
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.18	0.41	0.24	-0.73	-1.24
Free Cash Flow per Share ($)	--	-0.03	0.14	0.00	-1.14	-1.37

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-28.95	-89.79	-208.72	-350.30	-391.39
ROE (%)	-138.09	-80.43	1,907.12	1,239.01	-454.88	-431.83
ROA (%)	-17.45	-9.95	-28.84	-48.95	-120.48	-192.33
EBIT Margin (%)	-6.39	-4.55	-7.60	-9.71	-33.34	-62.77
Net Margin (%)	-10.40	-3.66	-8.89	-13.50	-38.25	-68.52
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-16.69	-0.09	0.39	0.28	0.28	1.49
EBIT Growth (%)	-874.10	45.33	-8.98	62.67	31.92	-0.83
Net Profit Growth (%)	-231.28	62.36	8.32	54.77	25.23	-0.62
EPS Growth (%)	-247.02	0.66	0.20	0.61	0.36	0.53
Book Value Growth (%)	515.24	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-22.44	-11.06	-14.78	-1.34	-1.70
Price / Book Value	18.48	6.89	-38.09	86.82	-8.92	3.85
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	26.79	-85.05	-29.91	-35.32	-1.58	-1.10
Close Price ($)	4.13	3.41	4.95	8.29	1.94	3.87
High Price ($)	13.63	15.84	12.88	9.11	4.33	33.02
Low Price ($)	2.56	3.18	3.99	1.14	1.72	3.70
Market Cap ($ Cr)	148.46	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.27	-4.58	5.40	-0.60	0.07
Short term debt to equity ratio	0.09	0.03	-1.63	0.27	-0.52	0.02
Current Ratio	0.90	1.25	0.81	1.22	0.36	1.97
Quick Ratio	0.84	1.18	0.76	1.15	0.24	1.90
Interest Coverage	-35.76	-6.48	-7.40	-5.71	-31.10	-19.31

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	5.62	4.80	3.87	3.46	2.38	1.06
Asset Turnover	1.68	2.72	3.25	3.63	3.15	2.93
Receivable days	--	16.49	11.60	9.71	5.85	3.89
Inventory Days	--	25.89	42.17	62.45	52.04	29.24
Payable days	--	140.17	205.58	204.76	187.50	197.56
Cash Conversion Cycle	--	-97.78	-151.82	-132.60	-129.60	-164.44

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.